{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:30:23Z","timestamp":1774927823708,"version":"3.50.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Type 2 diabetes mellitus (T2DM) and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) are mutually causal, which can jointly promote the development of the disease. As an important means to evaluate the steatosis of MAFLD, Controlled Attenuation Parameter (CAP) can also evaluate the metabolism related fat parameters. Whether Traditional Chinese Medicine preparation (TCM-preparation) can improve CAP has not been reported yet, so the purpose of this meta-analysis is to evaluate the effect of TCM-preparation on CAP in T2DM patients with MAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this meta-analysis, eight databases were searched from the establishment of the database to 23 April 2025, to obtain clinical randomized controlled trials of TCM-preparation or TCM-preparation combined with Standard Biomedical Treatment in the treatment of T2DM complicated with MAFLD. After screening the literature and extracting the data, Meta-analysis was conducted using RevMan5.4 software, with results presented in the form of a forest plot. This study was registered with PROSPERO (CRD42024569613).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 599 papers were retrieved, and the papers were screened according to the nadir and ranking criteria, and finally 8 trials (648 participants) were included in this study. Meta-analysis showed that TCM-preparation significantly reduced CAP values in patients with T2DM combined with MAFLD compared with TCM-preparation (MD = \u221215.19, CI [\u221222.53, \u22127.85], P &amp;lt; 0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>TCM-preparation can reduce the CAP value of T2DM combined with MAFLD and can have a good therapeutic effect on glucose-lipid metabolism level and liver function, indicating that TCM-preparation can reduce the deposition of hepatic fat, restore the function of hepatocytes, and have a positive effect on T2DM combined with MAFLD; however, due to the heterogeneity of the included literature, it needs to be further validation by high-quality trials.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1578371","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:34:15Z","timestamp":1755149655000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Metabolic dysfunction-associated fatty liver in type 2 diabetes mellitus patient: can a systematic review of and meta-analysis of commonly used TCM-preparation shed light on their efficacy?"],"prefix":"10.3389","volume":"16","author":[{"given":"Jingsi","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuechun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RuiXue","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changlong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"B1","volume-title":"IDF diabetes atlas","author":"Aguirre","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/s2213-8587(20)30303-x","article-title":"2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial","volume":"8","author":"Al-Mrabeh","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/HMER.S411619","article-title":"The accuracy of ultrasound controlled attenuation parameter in diagnosing hepatic fat content","volume":"15","author":"Atzori","year":"2023","journal-title":"Hepat. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/jhep.2000.16602","article-title":"Practices of liver biopsy in France: results of a prospective nationwide survey. For the group of epidemiology of the French association for the study of the liver (AFEF)","volume":"32","author":"Cadranel","year":"2000","journal-title":"Group Epidemiol. Fr. Assoc. Study Liver (AFEF). Hepatology32"},{"key":"B5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3969\/j.issn.1671-6450.2022.04.013","article-title":"Clinical efficacy of Jinlida granules combined with liraglutide in the treatment of type 2 diabetes mellitus complicated with metabolic-related fatty liver disease","volume":"21","author":"Cai","year":"2022","journal-title":"Chin. J. Difficult Complicat. Cases"},{"key":"B6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4314\/tjpr.v22i3.17","article-title":"Effect of jinlida granule on glycolipid metabolism, oxidative stress, and inflammatory factors in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease","volume":"22","author":"Cai","year":"2023","journal-title":"Trop. J. Pharm. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/gut.52.2.288","article-title":"Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies","volume":"52","author":"Cast\u00e9ra","year":"2003","journal-title":"Gut52"},{"key":"B8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3349\/ymj.2016.57.4.885","article-title":"The relationship between type 2 diabetes mellitus and non-alcoholic fatty liver disease measured by controlled attenuation parameter","volume":"57","author":"Chon","year":"2016","journal-title":"Yonsei Med. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13020-021-00469-4","article-title":"Traditional Chinese medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"16","author":"Dai","year":"2021","journal-title":"Chin. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real-time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jhep.2013.12.018","article-title":"Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations","volume":"60","author":"de L\u00e9dinghen","year":"2014","journal-title":"J. Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"728032","DOI":"10.3389\/fendo.2021.728032","article-title":"Syndrome differentiation and treatment regularity in traditional Chinese medicine for type 2 diabetes: a text mining analysis","volume":"12","author":"Dou","year":"2021","journal-title":"Front. Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/13880209.2022.2029501","article-title":"Jinlida granules ameliorate the high-fat-diet induced liver injury in mice by antagonising hepatocytes pyroptosis","volume":"60","author":"Hao","year":"2022","journal-title":"Pharm. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"739875","DOI":"10.3389\/fendo.2021.739875","article-title":"Validation of controlled attenuation parameter measured by FibroScan as a novel surrogate marker for the evaluation of metabolic derangement","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2337\/dc07-1463","article-title":"Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally Obese nondiabetic subjects","volume":"31","author":"Kotronen","year":"2008","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":"Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8377","DOI":"10.3748\/wjg.v20.i26.8377","article-title":"Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment","volume":"20","author":"Leite","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1023713","DOI":"10.3389\/fphar.2022.1023713","article-title":"Role of potential bioactive metabolites from traditional Chinese medicine for type 2 diabetes mellitus: an overview","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.13193\/j.issn.1673-7717.2022.06.032","article-title":"Effect of shenmai lanling decoction on liver fat content and fibrosis in type 2 diabetes mellitus with non-alcoholic fatty liver disease","volume":"40","author":"Li","year":"2022","journal-title":"Chin. J. Tradit. Chin. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13098-024-01399-5","article-title":"The correlation between hepatic controlled attenuation parameter (CAP) value and insulin resistance (IR) was stronger than that between body mass index, visceral fat area and IR","volume":"16","author":"Li","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jep.2014.12.040","article-title":"Jinlida reduces insulin resistance and ameliorates liver oxidative stress in high-fat fed rats","volume":"162","author":"Liu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal","volume":"58","author":"Machado","year":"2013","journal-title":"J. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/13880209.2024.2374794","article-title":"Evidence of traditional Chinese medicine for treating type 2 diabetes mellitus: from molecular mechanisms to clinical efficacy","volume":"62","author":"Ni","year":"2024","journal-title":"Pharm. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"863839","DOI":"10.3389\/fphar.2022.863839","article-title":"Chinese herbal medicine for type 2 diabetes mellitus with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbalip.2009.09.010","article-title":"n-3 PUFA and lipotoxicity","volume":"1801","author":"Perez-Martinez","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"B28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.13192\/j.issn.1000-1719.2023.09.042","article-title":"Effect of Huanglian Wendan decoction on blood glucose and lipid levels in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease of phlegm-heat syndrome","volume":"50","author":"Qian","year":"2023","journal-title":"Liaoning J. Tradit. Chin. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jhep.2017.12.029","article-title":"Controlled attenuation parameter and alcoholic hepatic steatosis: diagnostic accuracy and role of alcohol detoxification","volume":"68","author":"Thiele","year":"2018","journal-title":"J. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.13312\/j.issn.1671-7783.y230120","article-title":"Predictive value of hepatic steatosis related indexes in type 2 diabetespatients with non-alcoholic fatty liver disease","volume":"33","author":"Tian","year":"2023","journal-title":"J. Jiangsu University"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2755332","DOI":"10.1155\/2022\/2755332","article-title":"Clinical application of traditional Chinese medicine therapy for type 2 diabetes mellitus: an evidence map","volume":"2022","author":"Wang","year":"2022","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.20002\/j.issn.1000-7156.2024.02.007","article-title":"Clinical observation of wuling powder in treating type 2 diabetes mellitus with metabolic-associated fatty liver disease","volume":"40","author":"Wang","year":"2024","journal-title":"Shanxi J. Tradit. Chin. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.13193\/j.issn.1673-7717.2024.10.012","article-title":"Clinical efficacy of yixiao formula in treating type 2 diabetes mellitus with non-alcoholic fatty liver disease of Qi-Yin deficiency syndrome","volume":"39","author":"Wang","year":"2024","journal-title":"China J. Tradit. Chin. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1228722","DOI":"10.3389\/fphar.2023.1228722","article-title":"Berberine enhances the function of db\/db mice islet \u03b2 cell through GLP-1\/GLP-1R\/PKA signaling pathway in intestinal L cell and islet \u03b1 cell","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.19656\/j.cnki.1002-2406.20250109","article-title":"Clinical study of Quzhi Jiangtang formula in treating non-alcoholic fatty liver disease with type 2 diabetes mellitus of liver stagnation-spleen deficiency and damp-heat syndrome","volume":"42","author":"Wu","year":"2025","journal-title":"J. Info. Tradit. Chin. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"924021","DOI":"10.3389\/fphar.2022.924021","article-title":"Efficacy and mechanism of Jiedu Tongluo Tiaogan Formula in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease: study protocol for a parallel-armed, randomized controlled trial","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"671013","DOI":"10.1155\/2014\/671013","article-title":"Effects of Chaihu-Shugan-San and shen-ling-bai-zhu-san on p38 MAPK pathway in kupffer cells of nonalcoholic steatohepatitis","volume":"2014","author":"Yang","year":"2014","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3969\/j.issn.1002-266X.2024.02.024","article-title":"Research progress on the role of abnormal visceral fat accumulation in the occurrence and development of diabetic complications","volume":"64","author":"Yanni","year":"2024","journal-title":"Shandong Med. J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1407200","DOI":"10.3389\/fphar.2024.1407200","article-title":"Ginseng extract improves pancreatic islet injury and promotes \u03b2-cell regeneration in T2DM mice","volume":"15","author":"Yin","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","article-title":"The crucial role and mechanism of insulin resistance in metabolic disease","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Endocrinol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3969\/j.issn.1000-3649.2023.07.031","article-title":"Clinical study of Shenling Baizhu powder combined with Erchen decoction and exercise therapy in treating diabetes with non-alcoholic fatty liver","volume":"41","author":"Zhu","year":"2023","journal-title":"Sichuan J. Tradit. Chin. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1578371\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:34:23Z","timestamp":1755149663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1578371\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":46,"alternative-id":["10.3389\/fphar.2025.1578371"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1578371","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"article-number":"1578371"}}